Homeopathic Treatment of Positive Covid-19 Symptomatic Patients

Not Applicable

• Conditions: Residual effect of Covid-19; Anxiety; Unspecified depressive episode; B34.2

• Registration Number: RBR-4pn5whh
• Lead Sponsor: Faculdade de Medicina - Universidade do Estado de São Paulo (Unesp) - Campus Botucatu

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-04-13
• Study Completion: 2022-06-30
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Other
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients of both sexes; Present respiratory disease, with at least 3 (three) of the following symptoms: fever, chills, fatigue, myalgia, anorexia, sore throat, cough, expectoration, dyspnea, chest pain, headache, nasal congestion, conjunctival congestion, coryza , anosmia or hyposmia, dysgeusia, abdominal pain, diarrhea, rash; Present physical symptoms related to Covid-19 infection at the time of the first homeopathic consultation (symptomatic patients); Present a positive laboratory test (RT-PCR or serological) confirmed for COVID-19; Be = 18 years of age; Not having the following comorbidities:
severe heart disease (chronic or congenital), poorly controlled heart failure, poorly controlled COPD and asthma, cystic fibrosis with recurrent infections, chronic kidney disease at an advanced stage or undergoing dialysis, immunosuppressed, solid organ and bone marrow transplants; Sign the Free and Informed Consent Term (ICF) authorizing your participation in the research

Exclusion Criteria

Individuals who no longer wish to participate in the clinical follow-up performed by the physician; Patients who fail to follow the therapeutic guidelines for the use of homeopathic medication as recommended (misuse, discontinuation of use); Asymptomatic patients for Covid-19, even with positive serological test or RT-PCR.

Study & Design

• Study Type: Intervention
• Study Design: Not specified